Active Ingredient: DIFLUNISAL
Proprietary Name: DIFLUNISAL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A073679
Product Number: 001
Approval Date: Jul 31, 1992
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information